At a glance
- Originator Pfizer
- Class Osteoporosis therapies
- Mechanism of Action Growth hormone releasing factor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Osteoporosis
Most Recent Events
- 05 Sep 2006 Discontinued - Clinical-Phase-Unknown for Osteoporosis in USA (unspecified route)
- 25 Sep 2001 New profile
- 25 Sep 2001 Investigation in Osteoporosis in USA (Unknown route)